Related references
Note: Only part of the references are listed.Analysis of O-glycan heterogeneity in IgA1 myeloma proteins by Fourier transform ion cyclotron resonance mass spectrometry:: implications for IgA nephropathy
Matthew B. Renfrow et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2007)
Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels
Z. Moldoveanu et al.
KIDNEY INTERNATIONAL (2007)
Identification and characterization of CMP-NeuAc:GaINAc-IgA1 α2,6-sialyltransferase in IgA1-producing cells
Milan Raska et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Reactivities of N-acetylgalactosamine-specific lectins with human IgA1 proteins
Jennifer S. Moore et al.
MOLECULAR IMMUNOLOGY (2007)
IgA-containing immune complexes in the urine of IgA nephropathy patients
Karel Matousovic et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
IgA nephropathy
J Barratt et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Determination of aberrant O-glycosylation in the IgA1 hinge region by electron capture dissociation Fourier transform-ion cyclotron resonance mass spectrometry
MB Renfrow et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Increased levels of galactose-deficient IgG in sera of HIV-1-infected individuals
JS Moore et al.
AIDS (2005)
IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells
J Novak et al.
KIDNEY INTERNATIONAL (2005)
Aberrant glycosylation in IgA nephropathy (IgAN)
R Coppo et al.
KIDNEY INTERNATIONAL (2004)
Pathogenesis of IgA nephropathy
J Barratt et al.
SEMINARS IN NEPHROLOGY (2004)
New insights into the pathogenesis of IgA nephropathy - Pathogenesis of IgA nephropathy
AC Smith et al.
SPRINGER SEMINARS IN IMMUNOPATHOLOGY (2003)
Initiation of O-glycan synthesis in IgA1 hinge region is determined by a single enzyme, UDP-N-acetyl-α-D-galactosamine:: Polypeptide N-acetylgalactosaminyltransferase 2
H Iwasaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A unique molecular chaperone Cosmc required for activity of the mammalian core 1 β3-galactosyltransferase
TZ Ju et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Molecular cloning and characterization of a novel UDP-Gal:GaINAcα peptide β1,3-galactosyltransferase (ClGal-T2), an enzyme synthesizing a core 1 structure of O-glycan
T Kudo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Size-dependent binding of lgA to HepG2, U937, and human mesangial cells
JCK Leung et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2002)
Interactions of human mesangial cells with IgA and IgA-containing immune complexes
J Novak et al.
KIDNEY INTERNATIONAL (2002)
Pathogenic potential of galactose-deficient IgA1 in IgA nephropathy
J Mestecky et al.
NEPHROLOGY (2002)
Adaptive evolution of the IgA hinge region in primates
K Sumiyama et al.
MOLECULAR BIOLOGY AND EVOLUTION (2002)
Cloning and expression of human core 1 β1,3-galactosyltransferase
TZ Ju et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Progress in molecular and genetic studies of IgA nephropathy
J Novak et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2001)
Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: Observations in three patients
AC Allen et al.
KIDNEY INTERNATIONAL (2001)
Genetic remodeling of protein glycosylation in vivo induces autoimmune disease
D Chui et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Heterogeneity of O-glycosylation in the hinge region of human IgA1
J Novak et al.
MOLECULAR IMMUNOLOGY (2000)
Share Paper
